Rituximab treatment for fibrillary glomerulonephritis

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Volumn 29, Issue 10, 2014, Pages 1925-1931

  Hogan, Jonathan ^a   Restivo, Michaela ^a   Canetta, Pietro A ^a   Herlitz, Leal C ^a   Radhakrishnan, Jai ^a   Appel, Gerald B ^a   Bomback, Andrew S ^a  

^a Department of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; MONOCLONAL ANTIBODY; RITUXIMAB;

ADULT; AGED; DISEASE COURSE; DRUG EFFECTS; FEMALE; FIBER; FOLLOW UP; GLOMERULONEPHRITIS; GLOMERULUS FILTRATION RATE; HUMAN; MALE; MIDDLE AGED; PATHOLOGY; RETROSPECTIVE STUDY;

ADULT; AGED; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTINEOPLASTIC AGENTS; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; GLOMERULONEPHRITIS; HUMANS; MALE; MICROFIBRILS; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 84921739195     PISSN: None     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfu189     Document Type: Article

References (0)